Powerful Drugs Certainly not Charged To the Minimal Cash flow Client

There have been many new biological drugs approved by the FDA to take care of psoriasis since 2003 as an example of an inflated drug price that many lower income people can’t access because Medicaid and Medicare won’t purchase them because of the skyrocketing prices. The new blood thinner “Eliquis” is taken care of by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new will also be taken care of by the federal government without hesitation in your community of $150 a pop. Some states purchase the very expensive $400 and above hearing aids and some don’t. Why aren’t the new biological drugs that arrived to take care of psoriasis since 2003 taken care of by the federal government?

I suppose this really is one moment where I’m planning to answer the question I simply asked of this articles readers. In the above mentioned linked article I posted to go with this particular article mcdougal states these biological drugs to take care of psoriasis will NOT be available to people that are on Medicaid and Medicare as a result of price. All of the drug companies who’ve created their very own biological psoriasis treatments have pushed people on Medicaid and Medicare from receiving treatment with these drugs through the high cost of the drugs. Medicare Part D prescription drug plan will probably pay the bulk cost of “biological’s” but the co pay is between $1200 and $5000 which still keeps people from having the biological’s.

The spin is some of these biological drug companies have programs to provide the drugs absolve to low income patients who’ve private insurance only. Drug companies have stated in several articles I’ve read that if the patients have Medicare or Medicaid they will NOT be eligible for the free programs.

Quote From GoodRX.com: The lowest GoodRx price for the most common version of Humira is about $5,130.76, 38% off the typical retail price of $8,309.04.

These biological psoriasis treatments aren’t life saving so Medicare and Medicaid don’t recognize the inflated cost by drug companies as a necessary expense. The drug companies know this and want it this way. Back in 2003 when these biological psoriasis treatments were entering the drug marketplace these were affordable and insurance companies acquired the expenses if a reasonable deductible was paid. After 2012 the insurance companies started to get rid of people who have psoriasis as the payouts on the biological treatments were going up and getting extremely expensive.
The “Epipen Injector” used to take care of heroin overdoses was attacked viciously by the U.S. government when the owner of the business jacked up the purchase price so high only the truly wealthy could afford them. Medicaid and Medicare in a few states do cover generic Epipen’s but reject brand names. I’ve come to my conclusion about why this and other high drug costs are happening that keep many of these drugs out from the reach of several people that are on Medicare and Medicaid.

Come ON! obviously it’s collusion between the “Big Pharma” drug industry and members of congress. But once the collusion deals lose their freshness it’s the drug industry that’s forced to take the fall.

When these scams to get personal wealth come to light as in the opioid epidemic that’s ongoing now where billions of dollars are now being paid out by the drug companies to the states our congressional representatives who profited away from opioids though insider trading investments walk around without possibility of repercussion because of their involvement in the scheme.

If you appear at Canada which really is a country where government has to fund ALL healthcare costs you will dsicover the cheapest prices on quality drugs anywhere because the federal government forces prices down to reduce government expenditures. All of the drug companies that come up with high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought from destroying excessive profit taking by the drug companies since they are dedicated to these drug companies for their very own personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I simply bet ya if a person gained usage of the investments of our congressional leaders they would find many instances of drug company investments who’ve very high drug prices on popular needed drugs that really work to enhance a persons health. Congress voted to offer drug companies a 20 year patent before generics could be produced with a 5 year extension if certain conditions are met realizing that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time is now 12 years but I haven’t seen this 12 year patent time period in “Wikipedia” or anywhere else. All I see are 20 year patent time frames. I searched around and discovered following the drug is invented and a patent applied it might take around 8 years to have FDA approved which leaves 12 years for the drugs to stay on a patent.

Which of our congressional representatives would vote from this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they may increase their very own personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs as an example since they’ve only existed since 2003 or so. “Humira” was the first biological patent approved by the FDA for the treatment of Rheumatoid Arthritis. Down the road “Humira” was approved for the treatments of many other medical conditions including psoriasis.

If there is a 20 year patent on these drugs then “Humira” is likely to be priced out of reach of everyone until 2023 that was a massive profit taking window for congressional representatives. “Skyrizi” that will be new this year in 2019 is priced around “$15,000” for a one year kit that will be 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” removes 90% of psoriasis with the first two shots which are 4 weeks apart. “Skyrizi” will always be priced quite high until about 2039 when it has a 20 year patent.

When Humira comes away from patent in 2023 it’ll send the manufacturing of it to the generic drug companies and drop the purchase price to promote value which may mean everyone on Medicaid and Medicare could have a chance to be treated with it. All biological drug manufacturers will be required to drop their prices and also to an acceptable level because ALL doctors will direct their patents to Humira leaving other drug companies with a product that can’t be sold as a result of price. In “India” a common form of “Humira” is being manufactured and the monthly cost is just $400 that will be only down a couple of hundred from the discounted prices in the U.S.. After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it may cost a drug company over a billion dollars to produce a drug but this really is “Bull Hicky” ;.For starters think a drug company isn’t a drug company with no team of researchers. In reality a drug company is only researchers. A drug company after it starts making a benefit from the drugs they manufactured in the first place needs to budget for a permanent research team to produce future drug profits. The study team gets its paychecks from previous released drug sales always and forever and NO recouping of costs for the development of a new drug is ever needed. A drug company is really a huge laboratory filled with scientists that receives a commission regularly to produce new drugs and do constant experiments. No extra financial outputs are getting on to operate a vehicle drug prices through the roof.

Popular new releases of drugs are only total profit magnets for drug companies and congressional representatives. legal lean It’s like the city or city your home is in making you believe that the price to cope with an issue will exceed the taxes already collected to fund the staff and resources to cope with the issues that happen to be funded.

The “Stock Act” was enacted on April 4th, 2012 which required every person in congress to post their investment transactions on their websites within 45 days of making them for public viewing. Congressional representatives do not need their investments looked at nevertheless when public demand dictated so it become law to own their investments made public they had to offer into the general public demand and folded to it. Following a year congress went against public demand on April 15th 2013 and voted to kill the areas of what the law states that will make their investments public. Congress couldn’t fulfill themselves at the trouble of U.S. Citizens with riches galore through insider trading which they think they’ve a right to complete since there’s no legal entity that may punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced low in 2012 and insurance companies taken care of them if an affordable deductible was paid by someone who’d an excellent job. After the marketplace for biological,s started to grow the marketplace became hijacked by the wealthy as a means to improve their personal values by increasing the prices and marketing these drugs to the wealthy and themselves that are the wealthy for massive profit taking. People have been getting their psoriasis drugs taken care of through their insurance companies were being dropped off their insurance plans. Although insurance carriers taken care of biological’s before 2012 low income Medicaid and Medicare patients still did not have usage of these drugs. Medicare Part D prescription plan pays the majority of cost but the copay is $1200 to $5000 dollars which means most Medicare patients do not need usage of biological’s.

There’s no other way you will look at it. “Epipen’s” were getting the same treatment, these were introduced at a lowered price then hijacked available simply to the wealthy which would produce high profits with decreased production costs. I keep running in to the hearing aid issues that were suppose to own been priced in to the tens and thousands of dollars then being reduced to under $700 that will be still to expensive and an arena of massive profit taking. Advanced computer parts are cheaper than hearing aids?

With these drug companies as has been any business who holds a monopoly on any needed or popular product through government mandate the larger prices only the wealthy can pay are dictated which means less production is likely to be needed that results in lower production costs and the same or maybe more profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Leave a Reply

Your email address will not be published.